Skip to main content
Journal cover image

Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.

Journal articles  - Journal Article
Yano, Y; Toshinai, K; Inokuchi, T; Kangawa, K; Shimada, K; Kario, K; Nakazato, M
Published in: Atherosclerosis
June 2009

OBJECTIVE: The coming obesity epidemic in elderly persons necessitates the establishment of new and easy-to-use cardiometabolic markers to identify individuals most likely to develop atherosclerosis among hypertensives. METHODS: We measured plasma HMW adiponectin and des-acyl ghrelin levels, and carotid-artery intima-media thickness (cIMT) in 263 elderly hypertensives (mean 72.6 years; 37%men). Other cardiometabolic markers, including metabolites, inflammation, and hemostasis, were also measured. RESULTS AND CONCLUSION: Both HMW adiponectin and des-acyl ghrelin levels were inversely correlated with obesity. The HMW adiponectin level was favorably associated with glucose and lipid metabolites, PAI-1 (all P<0.05), and hs-CRP (P=0.07) after adjustment for age, sex, and BMI; however, it had no correlations with cIMT. In contrast, although there were no correlations between des-acyl ghrelin and cardiometabolic markers, except for a positive association with the nitrite/nitrate (NO(x)) level (P=0.002), des-acyl ghrelin had a significant inverse correlation with cIMT (P=0.003). A multivariable regression analysis showed that des-acyl ghrelin, but not HMW adiponectin, was significantly associated with cIMT after adjusting for age, obesity, sex, smoking, 24-h BP, and other cardiometabolic factors (beta=-0.178, P=0.001). Moreover, the increased risk of cIMT among those with abdominal obesity compared with non-obesity (0.833+/-0.185 mm vs. 0.782+/-0.163 mm, P=0.019) was explained by the elevated 24-h BP and reduced des-acyl ghrelin level, but not by other cardiometabolic parameters. These associations were unchanged after adding NO(x) to the model. In conclusion, the des-acyl ghrelin level is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensives, and the pathologic pathway linking these factors is independent of its NO bioactivity.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Atherosclerosis

DOI

EISSN

1879-1484

Publication Date

June 2009

Volume

204

Issue

2

Start / End Page

590 / 594

Location

Ireland

Related Subject Headings

  • Ultrasonography
  • Risk Factors
  • Risk Assessment
  • Regression Analysis
  • Predictive Value of Tests
  • Plasminogen Activator Inhibitor 1
  • Obesity
  • Nitrites
  • Nitrates
  • Molecular Weight
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yano, Y., Toshinai, K., Inokuchi, T., Kangawa, K., Shimada, K., Kario, K., & Nakazato, M. (2009). Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis, 204(2), 590–594. https://doi.org/10.1016/j.atherosclerosis.2008.10.013
Yano, Yuichiro, Koji Toshinai, Takashi Inokuchi, Kenji Kangawa, Kazuyuki Shimada, Kazuomi Kario, and Masamitsu Nakazato. “Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.Atherosclerosis 204, no. 2 (June 2009): 590–94. https://doi.org/10.1016/j.atherosclerosis.2008.10.013.
Yano Y, Toshinai K, Inokuchi T, Kangawa K, Shimada K, Kario K, et al. Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis. 2009 Jun;204(2):590–4.
Yano, Yuichiro, et al. “Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.Atherosclerosis, vol. 204, no. 2, June 2009, pp. 590–94. Pubmed, doi:10.1016/j.atherosclerosis.2008.10.013.
Yano Y, Toshinai K, Inokuchi T, Kangawa K, Shimada K, Kario K, Nakazato M. Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis. 2009 Jun;204(2):590–594.
Journal cover image

Published In

Atherosclerosis

DOI

EISSN

1879-1484

Publication Date

June 2009

Volume

204

Issue

2

Start / End Page

590 / 594

Location

Ireland

Related Subject Headings

  • Ultrasonography
  • Risk Factors
  • Risk Assessment
  • Regression Analysis
  • Predictive Value of Tests
  • Plasminogen Activator Inhibitor 1
  • Obesity
  • Nitrites
  • Nitrates
  • Molecular Weight